Personalized antibiotic duration for hospital pneumonia patients
Part of Infections, Lungs & breathing clinical trials.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and admitted to the hospital for suspected community-acquired pneumonia
- Have evidence of pneumonia on a chest X-ray or CT scan
- Have negative viral respiratory test results
- Be on antibiotics for pneumonia for at least 48 hours but no more than 6 days, and the last dose was within the past 24 hours
- Show early improvement in the last 24 hours: lower or normal temperature, normal heart and breathing rate, enough oxygen level, and stable blood pressure
- Have no serious complications like lung abscess or large fluid around the lung, and no other infection that needs different antibiotics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial compares azithromycin and doxycycline for adults hospitalized with community-acquired pneumonia who are already getting a beta-lactam antibiotic. It aims to see which works better as an add-on treatment.
This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.